Latest news
GILD Q2 Earnings Call Raises Outlook on HIV and PrEP Strength - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 13:02:32 GMTHIV Progress in Kenya: Building the Bridge to Breakthrough - Gilead SciencesGilead Sciences · Fri, 07 Aug 2026 09:16:23 GMTBridge to Breakthrough: Preventing HIV infections in Kenya, one conversation at a time - National GeographicNational Geographic · Thu, 06 Aug 2026 16:08:46 GMTViiV targets ‘future you’ in long-acting HIV campaign - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 12:46:16 GMTFreddie and CHAI launch "PrEP it Forward" to expand global access to HIV prevention - Clinton Health Access InitiativeClinton Health Access Initiative · Thu, 06 Aug 2026 12:31:37 GMTNew Bill to Repeal New York’s Gay Bathhouse Ban Is Long Overdue: What You Need to Know - Uncloseted MediaUncloseted Media · Thu, 06 Aug 2026 10:03:42 GMTThe Trump Administration’s Foreign Aid Review: Status of PEPFAR - KFFKFF · Thu, 06 Aug 2026 07:00:00 GMTGilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability - Fierce PharmaFierce Pharma · Wed, 05 Aug 2026 14:44:51 GMT